Home Articles List Article Information
Journal of Nanoanalysis
Journal Archive
Volume Volume 6 (2019)
Volume Volume 5 (2018)
Volume Volume 4 (2017)
Volume Volume 3 (2016)
Volume Volume 2 (2015)
Volume Volume 1 (2014)
Jomeh Farsangi, Z., Rezayat, S., Beitollahi, A., Sarkar, S., Jaafari, M., Amani, A. (2016). Hollow Mesoporous Silica Nanoparticles (HMSNs) Synthesis and in vitro Evaluation of Cisplatin Delivery. Journal of Nanoanalysis, 3(3), 120-127. doi: 10.22034/jna.2016.03.006
Zohreh Jomeh Farsangi; Seyed Mehdi Rezayat; Ali Beitollahi; Saeed Sarkar; Mahmoudreza Jaafari; Amir Amani. "Hollow Mesoporous Silica Nanoparticles (HMSNs) Synthesis and in vitro Evaluation of Cisplatin Delivery". Journal of Nanoanalysis, 3, 3, 2016, 120-127. doi: 10.22034/jna.2016.03.006
Jomeh Farsangi, Z., Rezayat, S., Beitollahi, A., Sarkar, S., Jaafari, M., Amani, A. (2016). 'Hollow Mesoporous Silica Nanoparticles (HMSNs) Synthesis and in vitro Evaluation of Cisplatin Delivery', Journal of Nanoanalysis, 3(3), pp. 120-127. doi: 10.22034/jna.2016.03.006
Jomeh Farsangi, Z., Rezayat, S., Beitollahi, A., Sarkar, S., Jaafari, M., Amani, A. Hollow Mesoporous Silica Nanoparticles (HMSNs) Synthesis and in vitro Evaluation of Cisplatin Delivery. Journal of Nanoanalysis, 2016; 3(3): 120-127. doi: 10.22034/jna.2016.03.006

Hollow Mesoporous Silica Nanoparticles (HMSNs) Synthesis and in vitro Evaluation of Cisplatin Delivery

Article 6, Volume 3, Issue 3, Autumn 2016, Page 120-127  XML PDF (1.22 MB)
Document Type: Original Research Paper
DOI: 10.22034/jna.2016.03.006
Authors
Zohreh Jomeh Farsangi1; Seyed Mehdi Rezayat* 1; Ali Beitollahi2; Saeed Sarkar1; Mahmoudreza Jaafari3; Amir Amani1
1School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Keshavarz Blvd., Tehran, Iran
2Center of Excellence for advanced Materials and processing, Iran University of Science and Technology, Narmak, Tehran, Iran
3Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract
Cisplatin continues to be a first line chemotherapy agent alone or in combination with other cytotoxic agents or
radiotherapy. Dose-limiting side effects, intrinsic and acquired resistance are the main reasons for inventing and developing new ways of delivering cisplatin. Biocompatible hollow porous materials offer high void volume, shell porosity, low density and controllable size which make them promising platforms for efficient drug delivery systems. In this study, hollow mesoporous silica nanoparticles (HMSNs) were successfully synthesized by a hard-templating method. Further, the synthesized HMSNs were studied by characterizing their morphology, nanostructure, specific surface area, particle size distribution and chemical composition using FESEM, HRTEM, N2-Sorption and FTIR techniques, respectively. The high specific surface area (1201 m2g-1) of the prepared HMSNs resulted in relatively high loading capacity of cisplatin (35 wt.%). Furthermore, release test performed at pH value of 7.4 showed a sustained release pattern. The cytotoxicity of the formulated drug was also examined in c26 colon carcinoma cell lines by MTT assay. The drug loaded HMSNs showed a lower toxicity than free drug due to the sustained drug release.
Keywords
Cisplatin; Hollow mesoporous silica; Drug delivery; Sustained release
Statistics
Article View: 2,415
PDF Download: 852